Showing results (11-20 of 676) with videos related to
Sort By:
Pageof 68
Expert Review of Neurotherapeutics|March 8, 2007
Interferon-beta1b in multiple sclerosisMathias Buttmann, Peter RieckmannTrends in Immunology|December 9, 2008
Naturally occurring auto-antibodies in homeostasis and diseaseHans U Lutz, Christoph J Binder, Srini KaveriJournal of Neuroimmunology|October 7, 2004
Interferon-beta induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosisMathias Buttmann, Cornelia Merzyn, Peter RieckmannAnnals of Neurology|October 31, 2007
Toward the development of rational therapies in multiple sclerosis: what is on the horizon?Bernhard Hemmer, Hans-Peter HartungCurrent Opinion in Neurology|March 27, 2025
Multiple sclerosis: advances and challenges in diagnosisSilvia Tenembaum, Hans-Peter HartungJournal of Neurology|April 17, 2002
Chemotherapy-induced peripheral neuropathyStefan Quasthoff, Hans Peter HartungClinical Neuropharmacology|January 12, 2010
Mechanism of action of oral fingolimod (FTY720) in multiple sclerosisJerold Chun, Hans-Peter HartungBiomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|July 21, 2020
Multiple sclerosis and COVID-19Jan Mares, Hans-Peter HartungCurrent Opinion in Neurology|March 26, 2025
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating successBruce Cree, Hans-Peter HartungArchives of Neurology|March 14, 2012
Volume transmission-mediated encephalopathies: a possible new concept?Hans-Peter Hartung, Marcel DihnéPageof 68